Any feedback?
Please rate this page
(enzyme.php)
(0/150)

BRENDA support

BRENDA Home
show all | hide all No of entries

Information on EC 3.4.24.84 - Ste24 endopeptidase and Organism(s) Homo sapiens and UniProt Accession O75844

for references in articles please use BRENDA:EC3.4.24.84
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
EC Tree
     3 Hydrolases
         3.4 Acting on peptide bonds (peptidases)
             3.4.24 Metalloendopeptidases
                3.4.24.84 Ste24 endopeptidase
Specify your search results
Select one or more organisms in this record: ?
This record set is specific for:
Homo sapiens
UNIPROT: O75844 not found.
Show additional data
Do not include text mining results
Include (text mining) results
Include results (AMENDA + additional results, but less precise)
Word Map
The taxonomic range for the selected organisms is: Homo sapiens
The expected taxonomic range for this enzyme is: Eukaryota, Bacteria, Archaea
Reaction Schemes
The peptide bond hydrolysed can be designated -C-/-aaX in which C is an S-isoprenylated cysteine residue, a is usually aliphatic and X is the C-terminal residue of the substrate protein, and may be any of several amino acids
Synonyms
zmpste24, ste24p, face-1, atste24, afc1p, hs ste24p, a-factor converting enzyme, more
SYNONYM
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
CAAX prenyl protease 1 homolog
-
FACE-1
-
-
Hs Ste24p
-
-
Ste24p
-
-
-
-
Zmpste24
-
-
REACTION TYPE
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
hydrolysis of peptide bond
-
-
-
-
CAS REGISTRY NUMBER
COMMENTARY hide
316364-97-3
-
SUBSTRATE
PRODUCT                       
REACTION DIAGRAM
ORGANISM
UNIPROT
COMMENTARY
(Substrate) hide
LITERATURE
(Substrate)
COMMENTARY
(Product) hide
LITERATURE
(Product)
Reversibility
r=reversible
ir=irreversible
?=not specified
a-factor + H2O
?
show the reaction diagram
-
-
-
?
a-factor-CaaX + H2O
a-factor-C + aaX
show the reaction diagram
-
-
-
?
Abz-K-SKTKC(farnesyl)VI(-dinitrophenyl derivative of lysine) + H2O
?
show the reaction diagram
-
-
-
?
METP-(639aa)-RSYLLGNSSPRTQSPQNC(farnesyl)-OCH3 + H2O
METP-(639aa)-RSY + LLGNSSPRTQSPQNC(farnesyl)-OCH3
show the reaction diagram
-
-
-
?
prelamin A + H2O
?
show the reaction diagram
the enzyme removes the farnesylated tail of prelamin A
-
-
?
prelamin A + H2O
lamin A + ?
show the reaction diagram
a-factor + H2O
?
show the reaction diagram
-
the enzyme has CAAX endopeptidase activity towards a-factor substrate
-
-
?
a-factor + H2O
fragments of a-factor
show the reaction diagram
N-(Ac)-Cys-(farnesyl)-Ser-Ile-Met + H2O
?
show the reaction diagram
-
the enzyme can process the prelaminA-specific CAAX sequence
-
-
?
prelamin A + H2O
lamin A
show the reaction diagram
-
cleavage is dependent on processing at the CAAX-box
-
-
?
additional information
?
-
NATURAL SUBSTRATE
NATURAL PRODUCT
REACTION DIAGRAM
ORGANISM
UNIPROT
COMMENTARY
(Substrate) hide
LITERATURE
(Substrate)
COMMENTARY
(Product) hide
LITERATURE
(Product)
REVERSIBILITY
r=reversible
ir=irreversible
?=not specified
a-factor + H2O
?
show the reaction diagram
-
-
-
?
a-factor-CaaX + H2O
a-factor-C + aaX
show the reaction diagram
-
-
-
?
METP-(639aa)-RSYLLGNSSPRTQSPQNC(farnesyl)-OCH3 + H2O
METP-(639aa)-RSY + LLGNSSPRTQSPQNC(farnesyl)-OCH3
show the reaction diagram
-
-
-
?
prelamin A + H2O
lamin A + ?
show the reaction diagram
METALS and IONS
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
Zn2+
-
Zn2+-dependent active site
additional information
INHIBITOR
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
IMAGE
atazanavir
-
darunavir
-
lopinavir
-
ritonavir
-
tipranavir
-
1,10-phenanthroline
-
Zn2+ chelator
benzyloxycarbonyl-Phe-Ala-2,4,6-trimethylbenzoyloxymethyl ketone
-
0.25 mM, 41% inhibition, inhibition is not reversible
benzyloxycarbonyl-Phe-Lys-2,4,6-trimethylbenzoyloxymethyl ketone
-
0.25 mM, 68% inhibition, inhibition is not reversible
lovastatin
-
abolishes the conversion of prelamin A into lamin A
additional information
-
Ki VALUE [mM]
INHIBITOR
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
IMAGE
0.049
atazanavir
at pH 7.5 and 25°C
0.05
darunavir
Ki above 0.05 mM, at pH 7.5 and 25°C
0.0056
lopinavir
at pH 7.5 and 25°C
0.015
ritonavir
at pH 7.5 and 25°C
0.0022
tipranavir
at pH 7.5 and 25°C
SPECIFIC ACTIVITY [µmol/min/mg]
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
173
wild-type, pH 7.5, 30°C
ORGANISM
COMMENTARY hide
LITERATURE
UNIPROT
SEQUENCE DB
SOURCE
SOURCE TISSUE
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
SOURCE
LOCALIZATION
ORGANISM
UNIPROT
COMMENTARY hide
GeneOntology No.
LITERATURE
SOURCE
GENERAL INFORMATION
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
malfunction
enzyme mutations cause the premature aging disease Hutchinson-Gilford progeria syndrome, and the related progeroid disorders mandibuloacral dysplasia type B and restrictive dermopathy
metabolism
the enzyme is crucial for the final step in the biogenesis of the nuclear scaffold protein lamin A
UNIPROT
ENTRY NAME
ORGANISM
NO. OF AA
NO. OF TRANSM. HELICES
MOLECULAR WEIGHT[Da]
SOURCE
SEQUENCE
LOCALIZATION PREDICTION?
FACE1_HUMAN
475
7
54813
Swiss-Prot
other Location (Reliability: 5)
MOLECULAR WEIGHT
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
54000
-
SDS-PAGE or immunoblot analyis
CRYSTALLIZATION (Commentary)
ORGANISM
UNIPROT
LITERATURE
sitting drop vapor diffusion method, using 24% (w/v) PEG 3350, 170 mM ammonium sulfate, 15% (v/v) glycerol
PROTEIN VARIANTS
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
H335A
H339A
the mutant shows 1.9% of wild type activity
L362F
L425P
the mutation is associated with mandibuloacral dysplasia type B and reduced prelamin A cleavage ability (41.9% of wild type activity)
L438F
L462R
the mutation is associated with restrictive dermopathy and reduced prelamin A cleavage ability (6.5% of wild type activity)
N265S
N265S/L362F
the mutations are associated with Hutchinson-Gilford progeria syndrome and reduced prelamin A cleavage ability
N265S/Y70S
the mutations are associated with mandibuloacral dysplasia type B and reduced prelamin A cleavage ability
P248L
P248L/Q41X
the mutations are associated with mandibuloacral dysplasia type B and reduced prelamin A cleavage ability
P248L/W450X
the mutations are associated with mandibuloacral dysplasia type B and reduced prelamin A cleavage ability
T159/L209del
no residual activity
W302X
the mutation is associated with restrictive dermopathy
W340R
W340R/L362F
the mutations are associated with mandibuloacral dysplasia type B and reduced prelamin A cleavage ability
W450X
0.3% of wild-type activity
Y399C
the mutation is associated with mandibuloacral dysplasia type B and reduced prelamin A cleavage ability(25.8% of wild type activity)
L647R
-
prelaminaAct mutant, cannot be cleaved by Zmpste24
additional information
PURIFICATION (Commentary)
ORGANISM
UNIPROT
LITERATURE
IgG Sepharose 6 column chromatography, nickel affinity resin column chromatography, and Superdex S200 gel filtration
Ni-bead-purified
-
CLONED (Commentary)
ORGANISM
UNIPROT
LITERATURE
expressed in Saccharomyces cerevisiae strain BJ5460
expressed in Sf-21 insect cells
-
expression in CHO-K1 cells
-
expression of Ste24 in Sacchromyces cerevisiae ste24DELTA mutant
-
Zmpste24, fused N-terminally to a His6 tag, cloned into the (5')-NheI-(3')-BamHI site of the pcDNA3.1 construct using reverse transcriptase-PCR on HeLa RNA, when cloned into pBacpak8
-
APPLICATION
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
medicine
mutations in the ZMPSTE24 gene lead to incomplete maturation of prelamin A and as a consequence to the premature aging disease Hutchinson-Gilford Progeria Syndrome. In general, the residual activity of ZMPSTE24 patient alleles correlates with disease severity. Complete loss-of-function alleles are associated with restrictive dermopathy, whereas retention of partial, measureable activity results in mandibuloacral dysplasia type B or severe progeria
medicine
REF.
AUTHORS
TITLE
JOURNAL
VOL.
PAGES
YEAR
ORGANISM (UNIPROT)
PUBMED ID
SOURCE
Tam, A.; Nouvet, F.J.; Fujimura-Kamada, K.; Slunt, H.; Sisodia, S.S.; Michaelis, S.
Dual roles for Ste24p in yeast a-factor maturation: NH2-terminal proteolysis and COOH-terminal CAAX processing
J. Cell Biol.
142
635-649
1998
Saccharomyces cerevisiae, Homo sapiens
Manually annotated by BRENDA team
Schmidt, W.K.; Tam, A.; Michaelis, S.
Reconstitution of the Ste24p-dependent N-terminal proteolytic step in yeast a-factor biogenesis
J. Biol. Chem.
275
6227-6233
2000
Saccharomyces cerevisiae, Homo sapiens
Manually annotated by BRENDA team
Bracha, K.; Lavy, M.; Yalovsky, S.
The Arabidopsis AtSTE24 is a CAAX protease with broad substrate specificity
J. Biol. Chem.
277
29856-29864
2002
Homo sapiens (O75844), Saccharomyces cerevisiae (P47154), Saccharomyces cerevisiae, Arabidopsis thaliana (Q8RX88)
Manually annotated by BRENDA team
Corrigan, D.P.; Kuszczak, D.; Rusinol, A.E.; Thewke, D.P.; Hrycyna, C.A.; Michaelis, S.; Sinensky, M.S.
Prelamin A endoproteolytic processing in vitro by recombinant Zmpste24
Biochem. J.
387
129-138
2005
Homo sapiens
Manually annotated by BRENDA team
Moulson, C.L.; Go, G.; Gardner, J.M.; van der Wal, A.C.; Smitt, J.H.; van Hagen, J.M.; Miner, J.H.
Homozygous and compound heterozygous mutations in ZMPSTE24 cause the laminopathy restrictive dermopathy
J. Invest. Dermatol.
125
913-919
2005
Homo sapiens
Manually annotated by BRENDA team
Porter, S.B.; Hildebrandt, E.R.; Breevoort, S.R.; Mokry, D.Z.; Dore, T.M.; Schmidt, W.K.
Inhibition of the CaaX proteases Rce1p and Ste24p by peptidyl (acyloxy)methyl ketones
Biochim. Biophys. Acta
1773
853-862
2007
Arabidopsis thaliana, Saccharomyces cerevisiae, Homo sapiens
Manually annotated by BRENDA team
Smigiel, R.; Jakubiak, A.; Esteves-Vieira, V.; Szela, K.; Halon, A.; Jurek, T.; Levy, N.; De Sandre-Giovannoli, A.
Novel frameshifting mutations of the ZMPSTE24 gene in two siblings affected with restrictive dermopathy and review of the mutations described in the literature
Am. J. Med. Genet. A
152A
447-452
2010
Homo sapiens
Manually annotated by BRENDA team
Goulbourne, C.N.; Vaux, D.J.
HIV protease inhibitors inhibit FACE1/ZMPSTE24: a mechanism for acquired lipodystrophy in patients on highly active antiretroviral therapy?
Biochem. Soc. Trans.
38
292-296
2010
Homo sapiens (O75844), Homo sapiens
Manually annotated by BRENDA team
Ahmad, Z.; Phadke, S.R.; Arch, E.; Glass, J.; Agarwal, A.K.; Garg, A.
Homozygous null mutations in ZMPSTE24 in restrictive dermopathy: evidence of genetic heterogeneity
Clin. Genet.
81
158-164
2012
Homo sapiens (O75844)
Manually annotated by BRENDA team
Barrowman, J.; Hamblet, C.; Kane, M.; Michaelis, S.
Requirements for efficient proteolytic cleavage of prelamin A by ZMPSTE24
PLoS ONE
7
e32120
2012
Homo sapiens (O75844), Homo sapiens
Manually annotated by BRENDA team
Spear, E.D.; Hsu, E.T.; Nie, L.; Carpenter, E.P.; Hrycyna, C.A.; Michaelis, S.
ZMPSTE24 missense mutations that cause progeroid diseases decrease prelamin A cleavage activity and/or protein stability
Dis. Model. Mech.
11
dmm033670
2018
Homo sapiens (O75844), Homo sapiens
Manually annotated by BRENDA team
Clark, K.M.; Jenkins, J.L.; Fedoriw, N.; Dumont, M.E.
Human CaaX protease ZMPSTE24 expressed in yeast Structure and inhibition by HIV protease inhibitors
Protein Sci.
26
242-257
2017
Homo sapiens (O75844), Homo sapiens
Manually annotated by BRENDA team